{"id":"https://openalex.org/W2201416092","doi":null,"title":"Clozapine for refractory schizophrenia: the Illinois experience.","display_name":"Clozapine for refractory schizophrenia: the Illinois experience.","alternate_titles":[],"publication_year":1999,"publication_date":"1999-01-01","ids":{"openalex":"https://openalex.org/W2201416092","mag":"2201416092","pmid":"https://pubmed.ncbi.nlm.nih.gov/10037166"},"language":"en","primary_location":{"id":"pmid:10037166","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10037166","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W2201416092"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"R W Buckman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4391767654","display_name":"State of Illinois","ror":"https://ror.org/025cbjw81","country_code":"US","type":"government","lineage":["https://openalex.org/I4391767654"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R W Buckman","raw_affiliation_strings":["Clinical Pharmacology Advisory Committee, The Drug Formulary, Department of Public Aid, State of Illinois, Springfield, USA. buckman@naper.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology Advisory Committee, The Drug Formulary, Department of Public Aid, State of Illinois, Springfield, USA. buckman@naper.com","institution_ids":["https://openalex.org/I4391767654"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042918834","display_name":"Randy D. Malan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R D Malan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.3627,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":{"value":0.78327898,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":93},"biblio":{"volume":"60 Suppl 1","issue":null,"first_page":"18","last_page":"30"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13944","display_name":"Psychiatric care and mental health services","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12666","display_name":"Historical Psychiatry and Medical Practices","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/clozapine","display_name":"clozapine","score":1.0},{"id":"https://openalex.org/keywords/treatment-resistant-schizophrenia","display_name":"treatment-resistant schizophrenia","score":0.9919999837875366},{"id":"https://openalex.org/keywords/psychiatric-inpatient-care","display_name":"psychiatric inpatient care","score":0.4830000102519989},{"id":"https://openalex.org/keywords/hospital-discharge","display_name":"hospital discharge","score":0.656000018119812},{"id":"https://openalex.org/keywords/community-reintegration","display_name":"community reintegration","score":0.6629999876022339},{"id":"https://openalex.org/keywords/cost-reduction","display_name":"cost reduction","score":0.640999972820282},{"id":"https://openalex.org/keywords/agranulocytosis","display_name":"agranulocytosis","score":0.9010000228881836},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.7099999785423279}],"concepts":[{"id":"https://openalex.org/C2780864610","wikidata":"https://www.wikidata.org/wiki/Q221361","display_name":"Clozapine","level":3,"score":0.9642044305801392},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.7046948671340942},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6193397641181946},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.58338463306427},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.5702308416366577},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.5484689474105835},{"id":"https://openalex.org/C3019878999","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic drug","level":4,"score":0.5066590905189514},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.47651803493499756},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.457922101020813},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.37690821290016174},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24321022629737854},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000465","descriptor_name":"Algorithms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002985","descriptor_name":"Clinical Protocols","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003024","descriptor_name":"Clozapine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003024","descriptor_name":"Clozapine","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D003024","descriptor_name":"Clozapine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006760","descriptor_name":"Hospitalization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007087","descriptor_name":"Illinois","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007256","descriptor_name":"Information Systems","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010054","descriptor_name":"Brief Psychiatric Rating Scale","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016527","descriptor_name":"Drug Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017048","descriptor_name":"Health Care Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:10037166","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10037166","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Journal Article"},{"id":"mag:2201416092","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10037166","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W43076824","https://openalex.org/W1990046779","https://openalex.org/W2115512786","https://openalex.org/W2914482488","https://openalex.org/W2416199967","https://openalex.org/W2038098219","https://openalex.org/W2166155862","https://openalex.org/W2123673366","https://openalex.org/W2079764852","https://openalex.org/W2567474044"],"abstract_inverted_index":{"Based":[0],"upon":[1],"the":[2,30,37,54,73,111,114,153],"Illinois":[3],"Department":[4],"of":[5,18,36,39,48,56,82,105,113],"Mental":[6],"Health":[7],"and":[8,33,75],"Developmental":[9],"Disabilities'":[10],"computerized":[11],"clinical":[12,20,31],"information":[13],"system,":[14],"with":[15,100,143],"its":[16],"integration":[17],"client-specific":[19],"data,":[21],"a":[22,101],"5-year":[23],"retrospective":[24],"study":[25,45],"was":[26,89,97],"designed":[27],"to":[28,72,119,134,149],"determine":[29],"effectiveness":[32],"economic":[34],"impact":[35],"use":[38],"clozapine":[40,136],"for":[41,80,138],"treatment-resistant":[42,51],"schizophrenia.":[43],"The":[44,95],"sample":[46],"consisted":[47],"518":[49],"hospitalized,":[50],"patients.":[52],"At":[53],"end":[55],"5":[57],"years,":[58],"78%":[59],"were":[60],"well":[61,98],"maintained":[62],"on":[63],"clozapine.":[64],"Two":[65],"hundred":[66],"forty-three":[67],"patients":[68,93,117,139],"had":[69,77],"been":[70,78,130],"discharged":[71],"community,":[74],"62":[76],"transferred":[79],"treatment":[81,88,137],"medical":[83],"or":[84],"surgical":[85],"problems.":[86],"Clozapine":[87],"discontinued":[90],"in":[91,160],"115":[92],"(22%).":[94],"drug":[96],"tolerated,":[99],"very":[102],"low":[103],"incidence":[104],"agranulocytosis.":[106],"Cost":[107],"savings":[108],"resulting":[109],"from":[110],"discharge":[112],"243":[115],"clozapine-treated":[116],"amounts":[118],"approximately":[120],"$20":[121],"million":[122],"per":[123],"year.":[124],"A":[125],"disease":[126],"management":[127],"algorithm":[128],"has":[129],"developed":[131],"allowing":[132],"physicians":[133],"begin":[135],"not":[140],"successfully":[141],"treated":[142],"2":[144],"prior":[145],"antipsychotic":[146],"agents.":[147],"Adherence":[148],"this":[150],"protocol":[151],"throughout":[152],"state's":[154],"mental":[155],"health":[156],"system":[157],"would":[158],"result":[159],"even":[161],"greater":[162],"savings.":[163]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2201416092","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
